Milos Miljkovic
Seminars
Thursday 4th December 2025
Panel Discussion: Discussing the Latest on the Need for Lymphodepletion in Cell Therapies to Improve Patient Access & Limit Therapeutic Side Effects
9:00 am
- Identify why lymphodepletion has been used in autoimmune cell therapies
- Examine the impact of lymphodepletion on patient recruitment and accessibility
- Consider the advantages and opportunities to remove preconditioning from therapies
Thursday 4th December 2025
Keynote Presentation: Clinical & Mechanistic Perspective on Bringing Cell Therapies to Autoimmune Disease
10:00 am
- Introducing RNA engineering for cell therapy
- Demonstrating deep and durable responses in patients receiving Descartes-08 without lymphodepletion or inpatient administration
- Insight into mechanisms behind Cartesian Therapeutics’ lead asset, Descartes-08
